No Data
No Data
Truking Technology (300358.SZ): The global workshop has partially started production, and the first phase of the polymer industrial park is about to start production.
On July 3, Gelonhui News reported that an investor asked Truking Technology (300358.SZ) on the investor interaction platform, "Has Chu Tian Global Workshop and Phase I of the Polymer Industrial Park started production?" The company replied that the global workshop has partially started production, and Phase I of the Polymer Industrial Park is about to commence.
Truking Technology (300358.SZ) shareholder has increased their shareholding in the company by a total of 657,400 shares.
Truking Technology (300358.SZ) announced that as of the announcement date, the term of the shareholding plan has expired and the plan has been completed. From the date of the shareholding plan announcement to the announcement disclosure date, the controlling shareholder Chu Tian Investment has accumulated 657,400 shares of the company through centralized bidding, accounting for 0.1114% of the total share capital, with a shareholding amount of 5.9989 million yuan (excluding transaction fees).
Chutian Technology (300358.SZ): ROMACO's revenue is expected to grow in 2024, and gross margin is also expected to grow
Gelonghui, May 24 | Chutian Technology (300358.SZ) was surveyed by a specific target on May 24. “What is the cause of ROMACO's low gross profit and net profit?” The company replied that ROMACO's net interest rate remains around 5%, and the scale benefits of the company's scale have not yet been shown. At the same time, the Russian-Ukrainian war affected its supply chain, and gross profit declined. There was a certain difference between ROMACO's gross profit calculation scale and that of the domestic market. ROMACO's revenue is expected to increase in 2024, and gross margin is also expected to increase.
Chutian Technology (300358.SZ): The company provides intelligent overall solutions for global pharmaceutical production customers, involving a wide range of drugs
Gelonghui, May 9丨Chutian Technology (300358.SZ) said on the investor interactive platform that the company provides global pharmaceutical production customers with intelligent overall solutions, involving a wide range of drugs. Insulin cell culture is only one type of drug. It involves fermentation, dosing, centrifugation, ultrafiltration, low-pressure chromatography, high-pressure chromatography, freeze-drying, filling, injection pen assembly, packaging, etc. We can provide equipment and services according to the actual needs of customers. It is part of the company's existing products. The specific data is based on the product sales data announced in the company's regular reports. Investors are requested to pay attention to investment risks and invest rationally.
Chutian Technology (300358.SZ): Reactors and other related equipment and consumables involved in the synthetic biology sector can be provided according to customer needs
Gelonghui, May 9 | Chutian Technology (300358.SZ) said on the investor interactive platform that related equipment and consumables such as reactors, purification systems, liquid dispensing systems, centrifugal separation systems, disposable bags, fillers, etc. involved in the synthetic biology sector can all be provided according to customer needs.
We Think That There Are More Issues For Truking Technology (SZSE:300358) Than Just Sluggish Earnings
No Data